Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Latest action · May 7, 2008 Referred to the Subcommittee on Health.
Progress
Where this resolution reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried. A concurrent resolution must be agreed to by both chambers, but it is not presented to the President and does not become law.
- IntroducedMay 6, 2008
- Agreed to in HouseNot reached
- Agreed to in SenateNot reached
Summary
Calls for the Food and Drug Administration (FDA) to reverse its policy that aims to eliminate patient access to compounded medications containing estriol prescribed by physicians.
Cosponsors 58
Members who signed on, in the order they did. Signatures ran from May 6, 2008 to Nov 19, 2008; 6 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-AZ | Gabrielle Giffords | Original | May 6, 2008 |
| R-MO | Jo Ann Emerson | Original | May 6, 2008 |
| R-TX | John R. Carter | Original | May 6, 2008 |
| R-TX | Michael C. Burgess | Original | May 6, 2008 |
| D-CA | Sam Farr | Original | May 6, 2008 |
| D-WI | Tammy Baldwin | Original | May 6, 2008 |
| R-TX | Ron Paul | May 22, 2008 | |
| R-TN | Zach Wamp | May 22, 2008 | |
| R-FL | Ginny Brown-Waite | Jun 3, 2008 | |
| R-TX | Kay Granger | Jun 3, 2008 | |
| R-TX | Mac Thornberry | Jun 3, 2008 | |
| R-TX | Ralph M. Hall | Jun 3, 2008 | |
| D-KY | Ben Chandler | Jun 4, 2008 | |
| R-CT | Christopher Shays | Jun 4, 2008 | |
| R-FL | Cliff Stearns | Jun 4, 2008 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred May 6, 2008 |
| Health Subcommittee | Referred May 7, 2008 |
Actions 3
Everything that happened, newest first.
- May 7, 2008Referred to the Subcommittee on Health.
- May 6, 2008Introduced in House
- May 6, 2008Referred to the House Committee on Energy and Commerce.
Research
What has been written about this resolution: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 1
Congressional Research Service work that CRS links to this resolution or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R42837 | Selected Resources on Federal Oversight of Compounding Pharmacies Archived | Report | Mar 21, 2013 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| SCONRES 88 | A concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. | Related bill | Jun 10, 2008 |
Titles 1
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- May 6, 2008Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this resolution on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
